Updated on 2026/04/12

Information

 

写真a

 
MASUDA AKITSU
 
Organization
Faculty of Agriculture Department of Bioresource Sciences Assistant Professor
Graduate School of Bioresource and Bioenvironmental Sciences Department of Bioresource Sciences(Concurrent)
School of Agriculture Department of Bioresource and Bioenvironment(Concurrent)
Title
Assistant Professor
Contact information
メールアドレス

Research Areas

  • Environmental Science/Agriculture Science / Insect science

  • Life Science / Molecular biology

Degree

  • Ph.D ( 2022.3 Kyushu University )

Research History

  • 九州大学 農学研究院 昆虫産業創生学研究室  テニュアトラック助教 

    2024.1 - Present

      More details

    Country:Japan

  • Kyushu University  Academic Researcher 

    2022.4 - 2023.12

      More details

    Country:Japan

  • 九州大学 農学研究院 昆虫産業創生学  Academic Researcher 

    2022.4 - 2023.12

      More details

    Country:Japan

  • 独立行政法人日本学術振興会 特別研究員(DC1)   

    2019.4 - 2022.3

  • 九州大学 生物資源環境科学府 昆虫ゲノム科学研究室 博士後期課程   

    2019.4 - 2022.3

      More details

    Country:Japan

Education

  • Kyushu University   生物資源環境科学府博士後期課程   資源生物科学専攻

    2019.4 - 2022.3

      More details

    Country:Japan

    Notes:博士課程

  • Kyushu University   生物資源環境科学府博士前期課程   資源生物科学専攻

    2017.4 - 2019.3

  • Kyushu University   農学部   生物資源環境学科

    2013.4 - 2017.3

Research Interests・Research Keywords

  • Research theme: ウイルス様粒子

    Keyword: ウイルス様粒子

    Research period: 2026

  • Research theme: タンパク質架橋

    Keyword: タンパク質架橋

    Research period: 2026

  • Research theme: サブユニットワクチン

    Keyword: サブユニットワクチン

    Research period: 2026

  • Research theme: コロナウイルス

    Keyword: コロナウイルス

    Research period: 2026

  • Research theme: カイコ-バキュロウイルス発現系

    Keyword: カイコ-バキュロウイルス発現系

    Research period: 2026

  • Research theme: Studies on functional modification of recombinant proteins produced in silkworms

    Keyword: Virus-like particles,antigen display,protein conjugation,protein stability

    Research period: 2024.1

  • Research theme: Production and functional evaluation of vaccine antigens using silkworm-baculovirus expression system

    Keyword: silkworm,baculovirus,vaccine,immunogenicity

    Research period: 2024.1

Awards

  • 学府賞

    2022.3   九州大学生物資源環境科学府  

    増田亮津

Papers

  • Characterization of high affinity IgM and IgG monoclonal antibodies against norovirus variants GII.4 and GII.17. Reviewed International journal

    Jumpei Tagawa, Saeko Yanaka, Yuri Kato, Akitsu Masuda, Jae Man Lee, Akinobu Senoo, Kosuke Oyama, Takayuki Uchihashi, Motohiro Nishida, Takahiro Kusakabe, Jose M M Caaveiro

    Protein science : a publication of the Protein Society   35 ( 4 )   e70522   2026.3   ISSN:0961-8368 eISSN:1469-896X

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Protein Science  

    Human noroviruses are a leading cause of acute gastroenteritis worldwide, yet the molecular principles governing antibody recognition of their highly repetitive capsid remain poorly understood. Here, we immunized mice with virus-like particles (VLPs) from the pandemic GII.4 strain and the emergent GII.17 strain, generating monoclonal IgM and IgG antibodies via hybridoma technology. High-speed atomic force microscopy visualized IgM antibodies scanning and engaging multiple protruding (P) domains on intact VLPs. Surface plasmon resonance (SPR) analyses of engineered antibodies with identical Fab sequences but different valencies revealed that, unlike monovalent IgG, multivalent IgM exhibits dramatic affinity gains-up to 100-fold-as antigen density increases. This avidity-driven enhancement arises from the dense, repetitive P-domain architecture of the norovirus capsid, enabling IgM to achieve high functional affinity despite modest intrinsic Fab binding. Our findings define how antibody valency and epitope organization cooperate to boost viral recognition, offering a mechanistic framework for designing next-generation vaccines and antiviral antibodies that harness multivalent engagement.

    DOI: 10.1002/pro.70522

    Web of Science

    Scopus

    PubMed

  • Production of Norovirus VLPs of the Nine Representative Genotypes Widely Distributed in Japan using the Silkworm-Baculovirus Expression Vector System Reviewed

    Yuto Tsurumi, Keisuke Morimoto, Akitsu Masuda, Jae Man Lee, Hiroaki Mon, Takahiro Kusakabe

    Journal of Virological Methods   331   115038 - 115038   2025.1   ISSN:01660934 eISSN:1879-0984

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Elsevier BV  

    Norovirus (NoV) is one of the major causes of acute viral gastroenteritis in humans. Genetic variation is abundant, and prevalent genotypes vary from year to year and region to region. Since NoVs are difficult to amplify in cultured cells, genome RNA-free virus-like particles (VLPs) that mimic the capsid structure of the virus are promising vaccine candidates for the prevention of NoVs infection, and the development of multivalent VLP vaccines is required to prevent NoV infection in a wide range of genotypes. In this study, we attempted to produce NoV VLPs of the top nine genotypes that have a history of epidemics in Japan using the silkworm-baculovirus expression vector system (silkworm-BEVS), which has a proven track record in the mass production of recombinant proteins. In silkworm pupae infected with recombinant baculoviruses constructed to express VP1s, the major protein that forms VLP, the NoV VP1 protein was expressed in large amounts. Most genotypes of VP1 accumulated in the cytoplasm as soluble proteins, but solubility was reduced for that of two genotypes. VP1s of five genotypes could be purified in large quantities (>0.9 mg per pupa) by a two-step purification process, and gel filtration chromatography analysis confirmed the formation of VLPs. This study demonstrates the utility of silkworm-BEVS in producing NoV VLPs of multiple genotypes and provides the basis for the development of a multivalent vaccine against genetically diverse NoV infections.

    DOI: 10.1016/j.jviromet.2024.115038

    Web of Science

    Scopus

    PubMed

  • Structural and stability differences among GI norovirus virus-like particles produced in silkworm-baculovirus expression vector system. Reviewed International journal

    Yuto Tsurumi, Akitsu Masuda, Jian Xu, Hiroaki Mon, Takahiro Kusakabe, Jae Man Lee

    Frontiers in microbiology   16   1739683 - 1739683   2025   ISSN:1664-302X eISSN:1664-302X

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Frontiers in Microbiology  

    Norovirus (NoV) is a leading cause of acute gastroenteritis worldwide, with genogroups I and II (GI and GII) most frequently detected. NoV Virus-like particles (VLPs) composed of the major capsid protein VP1 (~60 kDa) are essential for vaccine development, yet GI VLPs remain poorly characterized. In this study, VP1 from four epidemiologically relevant GI genotypes was expressed using the silkworm-baculovirus system, and purification conditions were optimized in a genotype-specific manner. Purified VLPs were analyzed using size-exclusion chromatography (SEC), dynamic light scattering (DLS), transmission electron microscopy (TEM), and differential scanning fluorimetry (DSF), and their functional epitopes confirmed via binding to histo-blood group antigens (HBGAs) mimics. Stability assessments revealed genotype-dependent differences in pH and thermal tolerance, including aggregation and structural transitions. Collectively, these findings define genotype-specific purification, structural characterization, and stability profiles for four GI NoV VLPs. This work provides the first systematic framework for understanding GI-specific constraints in VLP production and offers foundational data that directly inform the design and formulation of multivalent NoV vaccines.

    DOI: 10.3389/fmicb.2025.1739683

    Web of Science

    Scopus

    PubMed

  • Diabetic Mice Spleen Vulnerability Contributes to Decreased Persistence of Antibody Production after SARS-CoV-2 Vaccine. Reviewed International journal

    Yara Atef, Tomoya Ito, Akitsu Masuda, Yuri Kato, Akiyuki Nishimura, Yasunari Kanda, Jun Kunisawa, Takahiro Kusakabe, Motohiro Nishida

    International journal of molecular sciences   25 ( 19 )   2024.10   ISSN:1661-6596 eISSN:1422-0067

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:International Journal of Molecular Sciences  

    During the COVID-19 pandemic, diabetic and obese patients experienced higher rates of hospital admissions, severe illness, and mortality. However, vaccinations failed to provide those vulnerable populations the same level of protection against COVID-19 severity as those without diabetic and obese phenotypes. Our study aimed to investigate how diabetes mellitus (DM) impacts the immune response following vaccination including the artificially designed trimeric SARS-CoV-2 spike (S)-protein. By using two diabetic mouse models, ob/ob mice (obese, hyperglycemic, and insulin-resistant) and STZ-treated mice (insulin-deficient and hyperglycemic), we observed a significant reduction in S-protein-specific IgG antibody titer post-vaccination in both diabetic models compared to wild-type (WT) mice. Both diabetic mouse models exhibited significant abnormalities in spleen tissue, including marked reductions in splenic weight and the size of the white pulp regions. Furthermore, the splenic T-cell and B-cell zones were notably diminished, suggesting an underlying immune dysfunction that could contribute to impaired antibody production. Notably, vaccination with the S-protein, when paired with an optimal adjuvant, did not exacerbate diabetic cardiomyopathy, blood glucose levels, or liver function, providing reassurance about the vaccine's safety. These findings offer valuable insights into potential mechanisms responsible for the decreased persistence of antibody production in diabetic patients.

    DOI: 10.3390/ijms251910379

    Web of Science

    Scopus

    PubMed

  • Effective expression and characterization of the receptor binding domains in SARS-CoV-2 Spike proteins from original strain and variants of concern using Bombyx mori nucleopolyhedrovirus in silkworm Reviewed

    Akira Tsukamoto, Lee Jae Man, Kosuke Oyama, Akitsu Masuda, Hiroaki Mon, Tadashi Ueda, Takahiro Kusakabe

    Protein Expression and Purification   218   106450 - 106450   2024.6   ISSN:1046-5928 eISSN:1096-0279

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Elsevier BV  

    A new coronavirus, known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is responsible for the global pandemic of COVID-19 in 2020. Through structural analysis, it was found that several amino acid residues in the human angiotensin-converting enzyme-2 (hACE2) receptor directly interact with those in the receptor binding domain (RBD) of the spike glycoprotein (S-protein). Various cell lines, including HEK293, HeLa cells, and the baculovirus expression vector system (BEVS) with the insect cell line Sf9, have been utilized to produce the RBD. In this study, we investigated the use of Bombyx mori nucleopolyhedrovirus (BmNPV) and BEVS. For efficient production of a highly pure recombinant RBD protein, we designed it with two tags (His tag and STREP tag) at the C-terminus and a solubilizing tag (SUMO) at the N-terminus. After expressing the protein using BmNPV and silkworm and purifying it with a HisTrap excel column, the eluted protein was digested with SUMO protease and further purified using a Strep-Tactin Superflow column. As a result, we obtained the RBD as a monomer with a yield of 2.6 mg/10 mL serum (equivalent to 30 silkworms). The RBD showed an affinity for the hACE2 receptor. Additionally, the RBDs from the Alpha, Beta, Gamma, Delta, and Omicron variants were expressed and purified using the same protocol. It was found that the RBD from the Alpha, Beta, Gamma, and Delta variants could be obtained with yields of 1.4–2.6 mg/10 mL serum and had an affinity to the hACE2 receptor.

    DOI: 10.1016/j.pep.2024.106450

    Web of Science

    Scopus

    PubMed

  • Characterization of high affinity IgM and IgG monoclonal antibodies against norovirus variants GII.4 and GII.17

    2024.5

     More details

  • SARS-CoV-2 strain-specific anti-Spike IgG ELISA utilizing spike protein produced by silkworms Reviewed

    Takeyuki Goto, Tomoki Sasaki, Yong Chong, Masahiro Taniguchi, Jae Man Lee, Akitsu Masuda, Takeru Ebihara, Kenichiro Shiraishi, Naoki Tani, Akiko Yonekawa, Kei Gondo, Hiroyuki Kuwano, Nobuyuki Shimono, Hideyuki Ikematsu, Koichi Akashi, Takahiro Kusakabe

    Human Antibodies   31 ( 3 )   27 - 33   2023.9   ISSN:10932607 eISSN:1875-869X

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:IOS Press  

    BACKGROUND: A cost-effective and eco-friendly method is needed for the assessment of humoral immunity against SARS-CoV-2 in large populations. OBJECTIVE: We investigated the performance of an ELISA that uses silkworm-produced proteins to quantify the strain-specific anti-Spike IgG (anti-S IgG) titer. METHODS: The OD values for the anti-His-tag antibody, a standard material of ELISA quantification, were measured. Correlations between the ELISA for each strain and the Abbott SARS-CoV-2 IgG II Quant assay for the wild type were evaluated with serum samples from nine participants with various infection and vaccination statuses. RESULTS: Linear dose-responses were confirmed by high coefficients of determination: 0.994, 0.994, and 0.996 for the wild-type, Delta, and Omicron (BA.1) strain assays, respectively. The coefficient of determination for the wild-type and Delta strain assays was high at 0.959 and 0.892, respectively, while the Omicron strain assay had a relatively low value of 0.563. Booster vaccinees showed similar or higher titers against all strains compared to infected persons without vaccination. The Omicron-infected persons without vaccination had lower antibody titers against wild type than did the vaccinated persons. CONCLUSIONS: This study provides data indicating that the ELISA with silkworm-produced proteins makes it possible to discriminate and quantify the strain-specific anti-S IgG antibody induced by vaccination or infection.

    DOI: 10.3233/HAB-230006

    Scopus

    PubMed

  • Comprehensive Transcriptome Analysis in the Testis of the Silkworm, Bombyx mori Reviewed

    Kohei Kakino, Hiroaki Mon, Takeru Ebihara, Masato Hino, Akitsu Masuda, Jae Man Lee, Takahiro Kusakabe

    Insects   14 ( 8 )   684 - 684   2023.8   ISSN:2075-4450 eISSN:2075-4450

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:MDPI AG  

    Spermatogenesis is an important process in reproduction and is conserved across species, but in Bombyx mori, it shows peculiarities, such as the maintenance of spermatogonia by apical cells and fertilization by dimorphic spermatozoa. In this study, we attempted to characterize the genes expressed in the testis of B. mori, focusing on aspects of expression patterns and gene function by transcriptome comparisons between different tissues, internal testis regions, and Drosophila melanogaster. The transcriptome analysis of 12 tissues of B. mori, including those of testis, revealed the widespread gene expression of 20,962 genes and 1705 testis-specific genes. A comparative analysis of the stem region (SR) and differentiated regions (DR) of the testis revealed 4554 and 3980 specific-enriched genes, respectively. In addition, comparisons with D. melanogaster testis transcriptome revealed homologs of 1204 SR and 389 DR specific-enriched genes that were similarly expressed in equivalent regions of Drosophila testis. Moreover, gene ontology (GO) enrichment analysis was performed for SR-specific enriched genes and DR-specific enriched genes, and the GO terms of several biological processes were enriched, confirming previous findings. This study advances our understanding of spermatogenesis in B. mori and provides an important basis for future research, filling a knowledge gap between fly and mammalian studies.

    DOI: 10.3390/insects14080684

    Web of Science

    Scopus

    PubMed

  • The biological role of core 1β1-3galactosyltransferase (T-synthase) in mucin-type O-glycosylation in Silkworm, Bombyx mori Reviewed

    Akihiro Morio, Jae Man Lee, Tsuguru Fujii, Hiroaki Mon, Akitsu Masuda, Kohei Kakino, Jian Xu, Yutaka Banno, Takahiro Kusakabe

    Insect Biochemistry and Molecular Biology   156   103936 - 103936   2023.5   ISSN:0965-1748 eISSN:1879-0240

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Elsevier BV  

    O-glycosylation of secreted and membrane-bound proteins is an important post-translational modification that affects recognition of cell surface receptors, protein folding, and stability. However, despite the importance of O-linked glycans, their biological functions have not yet been fully elucidated and the synthetic pathway of O-glycosylation has not been investigated in detail, especially in the silkworm. In this study, we aimed to investigate O-glycosylation in silkworms by analyzing the overall structural profiles of mucin-type O-glycans using LC–MS. We found GalNAc or GlcNAc monosaccharide and core 1 disaccharide (Galβ1-3-GalNAcα1-Ser/Thr) were major components of the O-glycan attached to secreted proteins produced in silkworms. Furthermore, we characterized the 1 b1,3-galactosyltransferase (T-synthase) required for synthesis of the core 1 structure, common to many animals. Five transcriptional variants and four protein isoforms were identified in silkworms, and the biological functions of these isoforms were investigated. We found that BmT-synthase isoforms 1 and 2 were localized in the Golgi apparatus in cultured BmN4 cells and functioned both in cultured cells and silkworms. Additionally, a specific functional domain of T-synthase, called the stem domain, was found to be essential for activity and is presumed to be needed for dimer formation and galactosyltransferase activity. Altogether, our results elucidated the O-glycan profile and function of T-synthase in the silkworm. Our findings allow the practical comprehension of O-glycosylation required for employing silkworms as a productive expression system.

    DOI: 10.1016/j.ibmb.2023.103936

    Web of Science

    Scopus

    PubMed

  • High yield production of norovirus GII.4 virus-like particles using silkworm pupae and evaluation of their protective immunogenicity

    Masuda, A; Lee, JM; Miyata, T; Sato, S; Masuda, A; Taniguchi, M; Fujita, R; Ushijima, H; Morimoto, K; Ebihara, T; Hino, M; Kakino, K; Mon, H; Kusakabe, T

    VACCINE   41 ( 3 )   766 - 777   2023.1   ISSN:0264-410X eISSN:1873-2518

     More details

    Language:English   Publisher:Vaccine  

    Noroviruses (NoVs) are one of the major causes of acute viral gastroenteritis in humans. Virus-like particles (VLPs) without genomes that mimic the capsid structure of viruses are promising vaccine candidates for the prevention of NoVs infection. To produce large amounts of recombinant protein, including VLPs, the silkworm-expression vector system (silkworm-BEVS) is an efficient and powerful tool. In this study, we constructed a recombinant baculovirus that expresses VP1 protein, the major structural protein of NoV GII.4. Expression analysis showed that the baculovirus-infected silkworm pupae expressed NoV VP1 protein more efficiently than silkworm larval fat bodies. We obtained about 4.9 mg of purified NoV VP1 protein from only five silkworm pupae. The purified VP1 protein was confirmed by dynamic light scattering and electron microscopy to form VLPs of approximately 40 nm in diameter. Antisera from mice immunized with the antigen blocked NoV VLPs binding to histo-blood group antigens of pig gastric mucin and also blocked NoV infection in intestinal epithelial cells derived from human induced pluripotent stem (iPS) cells. Our findings demonstrated that NoV VLP eliciting protective antibodies could be obtained in milligram quantities from a few silkworm pupae using the silkworm-BEVS.

    DOI: 10.1016/j.vaccine.2022.12.015

    Web of Science

    Scopus

    PubMed

  • Characterization of a Novel Heterochromatin Protein 1 Homolog "<i>HP1c</i>" in the Silkworm, <i>Bombyx mori</i>

    Hino, M; Tatsuke, T; Morio, A; Mon, H; Lee, JM; Masuda, A; Kakino, K; Tonooka, Y; Kusakabe, T

    INSECTS   13 ( 7 )   2022.7   ISSN:2075-4450 eISSN:2075-4450

     More details

    Language:English   Publisher:Insects  

    Heterochromatin protein 1 plays an important role in chromatin structure and gene expression regulation. Three HP1 genes have been found in Homo sapiens, and five HP1 genes have been reported in Drosophila melanogaster. On the other hand, in Bombyx mori, only two HP1 genes, BmHP1a and BmHP1b, were reported. In this research, we have reported the molecular and functional characterization of a novel Bombyx mori HP1 gene (BmHP1c), which had stronger transcriptional repression activity than BmHP1a. BmHP1a and BmHP1b is reported to form homo- and heterodimers, but in co-immunoprecipitation experiments, no homo- or hetero-dimer formation of BmHP1c with the other silkworm HP1s is detected. The intracellular localization of BmHP1c is not only in the nucleus but also in the cytoplasm like mammalian HP1γ. In contrast to human HP1a and b, all three BmHP1s were localized preferentially in the regions poorly stained with DAPI. Interestingly, the double knockdown of BmHP1a and b, but not BmHP1c with a or b, arrested the cell cycle at the G2/M phase. These results suggest that BmHP1c is not essential for cell progression and plays a different role than BmHP1a and BmHP1b.

    DOI: 10.3390/insects13070631

    Web of Science

    Scopus

    PubMed

  • Optimization of SARS-CoV-2 Spike Protein Expression in the Silkworm and Induction of Efficient Protective Immunity by Inoculation With Alum Adjuvants

    Masuda, A; Lee, JM; Miyata, T; Mon, H; Sato, K; Oyama, K; Sakurai, Y; Yasuda, J; Takahashi, D; Ueda, T; Kato, Y; Nishida, M; Karasaki, N; Kakino, K; Ebihara, T; Nagasato, T; Hino, M; Nakashima, A; Suzuki, K; Tonooka, Y; Tanaka, M; Moriyama, T; Nakatake, H; Fujita, R; Kusakabe, T

    FRONTIERS IN IMMUNOLOGY   12   803647   2022.1   ISSN:1664-3224

     More details

    Language:English   Publisher:Frontiers in Immunology  

    The newly emerged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is causing a spread of coronavirus disease 2019 (COVID-19) globally. In order to end the COVID-19 pandemic, an effective vaccine against SARS-CoV-2 must be produced at low cost and disseminated worldwide. The spike (S) protein of coronaviruses plays a pivotal role in the infection to host cells. Therefore, targeting the S protein is one of the most rational approaches in developing vaccines and therapeutic agents. In this study, we optimized the expression of secreted trimerized S protein of SARS-CoV-2 using a silkworm-baculovirus expression vector system and evaluated its immunogenicity in mice. The results showed that the S protein forming the trimeric structure was the most stable when the chicken cartilage matrix protein was used as the trimeric motif and could be purified in large amounts from the serum of silkworm larvae. The purified S protein efficiently induced antigen-specific antibodies in mouse serum without adjuvant, but its ability to induce neutralizing antibodies was low. After examining several adjuvants, the use of Alum adjuvant was the most effective in inducing strong neutralizing antibody induction. We also examined the adjuvant effect of paramylon from Euglena gracilis when administered with the S protein. Our results highlight the effectiveness and suitable construct design of the S protein produced in silkworms for the subunit vaccine development against SARS-CoV-2.

    DOI: 10.3389/fimmu.2021.803647

    Web of Science

    Scopus

    PubMed

▼display all

Presentations

  • カイコ-バキュロウイルス発現系を用いたナノ粒子化CSFワクチンの開発

    金子 大樹, 増田 亮津, 近藤 祐里奈, 和田 香里, 門 宏明, 日下部 宜宏, 李 在萬

    第76回日本生物工学会大会  2024.9 

     More details

    Event date: 2024.9

    Language:Japanese   Presentation type:Oral presentation (general)  

  • 組換えタンパク質生産性向上の目指したランダム突然変異によるカイコバキュロウイルス変異体の獲得

    渋谷美咲,海老原健,門宏明,李在萬,山口礼華,増田亮津,日野真人,藤田龍介,日下部宜宏

    蚕糸・昆虫機能利用学術講演会  2024.3 

     More details

    Event date: 2024.3

    Language:Japanese   Presentation type:Oral presentation (general)  

  • ヒトノロウイルスVLPを形成するVP1タンパク質の不溶性原因の解明と可溶性向上

    #鶴見祐土,#増田亮津,#李在萬,#門宏明,#藤田龍介,#日野真人,#藤井告,#日下部宜宏

    蚕糸・昆虫機能利用学術講演会  2024.3 

     More details

    Event date: 2024.3

    Language:Japanese   Presentation type:Oral presentation (general)  

    Venue:農林水産技術会議事務局筑波産学連携支援センター   Country:Japan  

  • 組換えタンパク質生産性向上の目指したランダム突然変異によるカイコバキュロウイルス変異体の獲得

    #渋谷美咲,#海老原健,#門宏明,#李在萬,#山口礼華,#増田亮津,#日野真人,#藤田龍介,#日下部宜宏

    蚕糸・昆虫機能利用学術講演会  2024.3 

     More details

    Event date: 2024.3

    Language:Japanese   Presentation type:Oral presentation (general)  

    Venue:農林水産技術会議事務局筑波産学連携支援センター   Country:Japan  

  • バキュロウイルス非必須遺伝子クラスター欠損株の構築とタンパク質発現解析

    #山口礼華,#海老原健,#門宏明,#李在萬,#藤田龍介,#増田亮津,#日野真人,#渋谷美咲,#日下部宜宏

    蚕糸・昆虫機能利用学術講演会  2024.3 

     More details

    Event date: 2024.3

    Language:Japanese   Presentation type:Oral presentation (general)  

    Venue:農林水産技術会議事務局筑波産学連携支援センター   Country:Japan  

  • カイコバキュロウイルス発現系を用いた高機能化多価ワクチン開発のための足場タンパク質ナノ粒子の探索

    #河合雄貴,#李在萬,#増田亮津,#日野真人,#藤田龍介,#日下部宜宏

    蚕糸・昆虫機能利用学術講演会  2024.3 

     More details

    Event date: 2024.3

    Language:Japanese   Presentation type:Oral presentation (general)  

    Venue:農林水産技術会議事務局筑波産学連携支援センター   Country:Japan  

  • カイコバキュロウイルス発現系を用いた高機能化多価ワクチン開発のための足場タンパク質ナノ粒子の探索

    河合雄貴, 李在萬, 増田亮津, 日野真人, 藤田龍介, 日下部宜宏

    蚕糸・昆虫機能利用学術講演会  2024.3 

     More details

    Event date: 2024.3

    Language:Japanese   Presentation type:Oral presentation (general)  

  • ヒトノロウイルスVLPを形成するVP1タンパク質の不溶性原因の解明と可溶性向上

    鶴見祐土, 増田亮津, 李在萬, 門宏明, 藤田龍介, 日野真人, 藤井告, 日下部宜宏

    蚕糸・昆虫機能利用学術講演会  2024.3 

     More details

    Event date: 2024.3

    Language:Japanese   Presentation type:Oral presentation (general)  

  • バキュロウイルス非必須遺伝子クラスター欠損株の構築とタンパク質発現解析

    山口礼華, 海老原健, 門宏明, 李在萬, 藤田龍介, 増田亮津, 日野真人, 渋谷美咲, 日下部宜宏

    蚕糸・昆虫機能利用学術講演会  2024.3 

     More details

    Event date: 2024.3

    Language:Japanese   Presentation type:Oral presentation (general)  

  • カイコ-バキュロウイルス発現系を用いたナノ粒子化CSFワクチンの開発

    金子 大樹, 増田 亮津, 近藤 祐里奈, 和田 香里, 門 宏明, 日下部 宜宏, 李 在萬

    日本生物工学会大会講演要旨集  2024.8  (公社)日本生物工学会

     More details

    Language:Japanese  

  • proteinMPNNを活用したカイコ発現系での機能タンパク質リデザインの試み

    増田 亮津, 李 在萬, 門 宏明, 日下部 宜宏

    令和 7 度蚕糸・昆虫機能利用学術講演会  2025.3 

     More details

    Language:Japanese   Presentation type:Oral presentation (general)  

  • カイコ-BEVSを用いたアフリカ豚熱ウイルスに対するサブユニットワクチンの開発

    近藤 祐里菜, 金子 大樹, 増田 亮津, 門 宏明, 李 在萬, 日下部 宜宏

    令和 7 度蚕糸・昆虫機能利用学術講演会  2025.3 

     More details

    Language:Japanese   Presentation type:Oral presentation (general)  

  • カイコ-BEVSを用いた経口ワクチン用プラットフォームの構築

    和田 香里, 金子 大樹, 増田 亮津, 江畑 慶伍, 近藤 祐里菜, 門 宏明, 李 在萬, 日下部 宜宏

    令和 7 度蚕糸・昆虫機能利用学術講演会  2025.3 

     More details

    Language:Japanese   Presentation type:Oral presentation (general)  

  • カイコにおけるムチンタイプO型糖鎖形成に関わるT-synthaseの性質の解明

    江畑 慶伍, 李在萬, 藤井 告, 門 宏明, 藤田 龍介, 日野 真人, 増田 亮津, 齋木 雅大, 金子 大樹, 近藤 祐里奈, 和田 香里, 日下部 宜宏

    令和 7 度蚕糸・昆虫機能利用学術講演会  2025.3 

     More details

    Presentation type:Oral presentation (general)  

  • カイコによる組換えタンパク質ワクチン生産

    日下部 宜宏, 李 在萬, 門 宏明, 増田 亮津

    日本内視鏡外科学会雑誌  2024.12  (一社)日本内視鏡外科学会

     More details

    Language:Japanese  

  • タンパク質性アジュバントを付与した経口サブユニットワクチンプラットフォームの構築

    和田 香里, 金子 大樹, 増田 亮津, 門 宏明, 藤田 龍介, 藤井 告, 日野 真人, 日下部 宜宏, 李 在萬

    第48回日本分子生物学会年会  2025.12 

     More details

    Presentation type:Poster presentation  

  • カイコ蛹からの流行型HuNoV-VLPsの精製検討

    森本啓介, 増田亮津, 李在萬, 門宏明, 藤田龍介, 日下部宜宏

    第45回日本分子生物学会年会  2022.12 

     More details

    Presentation type:Poster presentation  

  • カイコ発現系における組換えノロウイルスGI.6 VP1の不溶性原因の解明

    鶴見 祐土, 増田 亮津, 谷原 智仁, 松永 直哉, 大戸 茂弘, 吉田 優哉, 寺田 悠真, 濵村 賢吾, 真柳 浩太, 李 在萬, 門 宏明, 日下部 宜宏

    第48回日本分子生物学会年会  2025.12 

     More details

    Presentation type:Poster presentation  

  • カイコ培養細胞を用いた機能未知遺伝子KWMTBOMO05087(No.118)のUPRとの関連解析

    田中 綾太, 谷 菜月, 門 宏明, 李 在萬, 増田 亮津, 日野 真人, 藤田 龍介, 日下部 宜宏

    第48回日本分子生物学会年会  2025.12 

     More details

    Presentation type:Poster presentation  

  • カイコにおけるムチンタイプO型糖鎖形成に関わるT-synthaseの性質の解明

    江畑 慶伍, 李在萬, 藤井 告, 門 宏明, 藤田 龍介, 日野 真人, 増田 亮津, 齋木 雅大, 金子 大樹, 近藤 祐里奈, 和田 香里, 日下部 宜宏

    令和 7 年度蚕糸・昆虫機能利用学術講演会  2025.3 

  • カイコ-バキュロウイルス発現系を用いた豚繁殖・呼吸障害症候群ウイルスに対する高分子化ワクチンの開発

    長谷川真理子, 李在萬, 増田亮津, 宮田健, 門宏明, 藤田龍介, 日下部宜宏

    第45回日本分子生物学会年会  2022.12 

     More details

    Presentation type:Poster presentation  

  • カイコ-バキュロウイルス発現系における、プロタンパク質転換システムの改変によるTGF-β成熟の効率化

    小山茜音, 李在萬, 増田亮津, 門宏明, 藤田龍介, 日下部宣宏

    第45回日本分子生物学会年会  2022.12 

     More details

    Presentation type:Poster presentation  

  • カイコ-BEVSを用いた経口ワクチン用プラットフォームの構築

    和田 香里, 金子 大樹, 増田 亮津, 江畑 慶伍, 近藤 祐里菜, 門 宏明, 李 在萬, 日下部 宜宏

    令和 7 年度蚕糸・昆虫機能利用学術講演会  2025.3 

  • カイコ-BEVSを用いたアフリカ豚熱ウイルスに対するサブユニットワクチンの開発

    近藤 祐里菜, 金子 大樹, 増田 亮津, 門 宏明, 李 在萬, 日下部 宜宏

    令和 7 年度蚕糸・昆虫機能利用学術講演会  2025.3 

  • アフリカ豚熱ウイルス(ASFV)に対するサブユニットワクチンの開発

    近藤 祐里菜, 増田 亮津, 金子 大樹, 江畑 慶伍, 和田 香里, 門 宏明, 日下部 宜宏, 李 在萬

    第48回日本分子生物学会年会  2025.12 

     More details

    Presentation type:Poster presentation  

  • proteinMPNNを活用したカイコ発現系での機能タンパク質リデザインの試み

    増田 亮津, 李 在萬, 門 宏明, 日下部 宜宏

    令和 7 年度蚕糸・昆虫機能利用学術講演会  2025.3 

  • Production of nine-gene Norovirus VLPs using a silkworm-baculovirus expression vector system and characterization of the VLPs

    Yuto Tsurumi, Jae Man Lee, Akitsu Masuda, Hiroaki Mon, Takahiro Kusakabe

    The 8th Asia-Pacific Congress of Sericulture and Insect Biotechnology  2025.9 

     More details

    Language:English   Presentation type:Oral presentation (general)  

  • Nanodiscテクノロジーとカイコ-バキュロウイルス発現系を融合した膜タンパク質の精製プラットフォーム

    江畑 慶伍, 増田 亮津, 日下部 宜宏, 門 宏明, 日野 真人, 李 在萬

    第48回日本分子生物学会年会  2025.12 

     More details

    Presentation type:Poster presentation  

  • Functional Characterization of a T -synthase Homolog and Investigation of Chaperone Involvement in the Silkworm, Bombyx mori

    Keigo Ebata, Akitsu Masuda, Takahiro Kusakabe, Tsuguru Fuji, Masato Hino, Hiroaki Mon, Ryosuke Fujita, Daiki Kaneko, Yurina Kondo, Kaori Wada, JaeMan Lee

    The 8th Asia-Pacific Congress of Sericulture and Insect Biotechnology  2025.9 

     More details

    Language:English   Presentation type:Poster presentation  

  • EFFICACY OF A VIRUS-LIKE PARTICLE VACCINE EXPRESSED IN SILKWORM PUPAE AGAINST 27A-LIKE PORCINE PARVOVIRUS 1

    Shizuka Hayashi, Keiichi Esaki, Hirokazu Nakatake, Masahiro Taniguchi, Ryosuke Takai, Akitsu Masuda, Jaeman Lee, Yo Nakahara, Kenta Yamato, Katsuaki Sugiura, Takahiro Kusakabe, Tetsuo Sato

    The 11th Asian Pig Veterinary Society Congress 2025  2025.11 

     More details

    Language:English   Presentation type:Poster presentation  

  • Development of scaffold protein nanoparticles for antigen-presenting vaccines using silkworm baculovirus expression system

    Yuki Kawai, Akitsu Masuda, Hiroaki Mon, Jae Man Lee, Ryosuke Fujita, Kusakabe Takahiro

    The 8th Asia-Pacific Congress of Sericulture and Insect Biotechnology  2025.9 

     More details

    Language:English   Presentation type:Oral presentation (general)  

  • Development of Oral Subunit Vaccine Platform Using Silkworm Baculovirus Expression Vector System

    Kaori Wada, Daiki Kaneko, Akitsu Masuda, Kusakabe Takahiro, Hiroaki Mon, Masato Hino, Ryosuke Fujita, Lee Jaeman

    The 8th Asia-Pacific Congress of Sericulture and Insect Biotechnology  2025.9 

     More details

    Language:English   Presentation type:Oral presentation (general)  

  • Development of CSF subunit vaccine using silkworm-baculovirus expression system

    Daiki Kaneko, Akitsu Masuda, Kaori Wada, Yurina Kondo, Keigo Ebata, Hiroaki Mon, Takahiro Kusakabe, Jae Man Lee

    The 8th Asia-Pacific Congress of Sericulture and Insect Biotechnology  2025.9 

     More details

    Language:English   Presentation type:Poster presentation  

  • Development and evaluation of highly proliferative silkworm cell lines, BmMAX7050np, for enhancing recombinant protein expression

    Abubakar Nura, Masato Hino, Jae Man Lee, Akitsu Masuda, Toshiaki Fujimoto, Hiroaki Mon, Tsuguru Fuji, Kusakabe Takahiro

    The 8th Asia-Pacific Congress of Sericulture and Insect Biotechnology  2025.9 

     More details

    Language:English   Presentation type:Oral presentation (general)  

  • COST-EFFECTIVE PRODUCTION OF PORCINE PARVOVIRUS 1 VACCINE USING SILKWORM-BACULOVIRUS EXPRESSION SYSTEM

    Keiichi Esaki, Tetsuo Sato, Shizuka Hayashi, Masahiro Taniguchi, Hirokazu Nakatake, Akitsu Masuda, Jae Man Lee, Nobuyuki Tsutsumi, Yo Nakahara, Kenta Yamato, Takahiro Kusakabe

    The 11th Asian Pig Veterinary Society Congress 2025  2025.11 

     More details

    Language:English   Presentation type:Poster presentation  

▼display all

MISC

  • 家畜感染症のための食べるワクチンの開発研究

    南奈津, 平松健太郎, 江崎啓一, 中武洋和, 佐々木友樹, 谷口雅浩, 二神泰基, 玉置尚徳, 増田亮津, 李在萬, 日下部宜宏, 宮田健

    日本食品科学工学会西日本支部大会講演要旨   2022   2022

     More details

  • カイコ発現系による細菌性毒素を応用した粘膜ワクチン用アジュバントの構築と機能性評価

    村田亜未, 里圭太, 玉城志博, 新川武, 増田亮津, 李在萬, 日下部宜宏, 宮田健

    日本食品科学工学会西日本支部大会講演要旨   2022   2022

     More details

Professional Memberships

  • 日本生物工学会

    2024.7 - Present

  • The Japanese Society Of Sericultural Science

  • The Molecular Biology Society of Japan

  • 日本蚕糸学会

  • 日本生物工学会

  • 日本分子生物学会

▼display all

Committee Memberships

  • The 8th Asia-Pacific Congress of Sericulture and Insect Biotechnology 運営委員会   The 8th Asia-Pacific Congress of Sericulture and Insect Biotechnology 運営委員   Foreign country

    2024.4 - Present   

      More details

    Committee type:Academic society

Research Projects

  • バキュロウイルスを利用した昆虫におけるタンパク質の指向性進化法の確立

    Grant number:25K18245  2025.4 - 2028.3

    Grants-in-Aid for Scientific Research  Grant-in-Aid for Early-Career Scientists

    増田 亮津

      More details

    Grant type:Scientific research funding

    本研究は、強力な有用物質生産系であるカイコ-バキュロウイルス発現系のさらなる改良のため、昆虫細胞内でバキュロウイルスアシストの元、指向性進化を起こすことによって生産したいタンパク質を目的の機能を持つように改変できる手法の開発を目的とする。そのために、昆虫細胞内で特定のDNA領域内にランダムな変異を高頻度で導入する技術の確立と、優良な変異体が自動的かつ効率的に選抜されるような技術を確立し、バキュロウイルス発現系におけるタンパク質の配列と機能の関係性を理解を進めるような指向性進化技術の開発を目指す。

    CiNii Research

  • タンパク質の配列redesign によるカイコ生産ウイルス様粒子の安定化

    2024.6 - 2025.3

    九州大学農学研究院  令和6 年度農学研究院研究者支援事業(チャレンジ研究支援(I 型)) 

    増田亮津

      More details

    Authorship:Principal investigator  Grant type:On-campus funds, funds, etc.

  • Development of a novel directed evolution method to improve recombinant protein productivity in insect factories

    Grant number:22K20581  2022 - 2023

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Research Activity start-up

    Masuda Akitsu

      More details

    Authorship:Principal investigator  Grant type:Scientific research funding

    In the silkworm-baculovirus expression system, which can efficiently produce recombinant proteins, it is known that there are some difficult-to-express proteins. Therefore, insect directed evolutionary tools that enable mutagenesis and selection of favourable mutants are needed to solve this problem. In this study, we attempted to develop a tool for introducing mutations into specific regions of the baculovirus genome and to identify baculovirus genes that affect viral proliferation, which is necessary for selecting desired mutants. The mutagenic enzyme was found to be expressed by the baculovirus in cultured insect cells, but no mutations in the target sequence were identified. In the identification of genes affecting viral proliferability, eight candidate genes were examined and several genes that could manipulate proliferability were identified.

    CiNii Research

  • ウイルス様粒子(VLP)表面への抗原提示法を用いた次世代型ワクチンの開発

    Grant number:19J21617 

    増田 亮津

      More details

    Grant type:Scientific research funding

    本研究は豚サーコウイルス2型(PCV2)のウイルス様粒子(VLP)の表面に豚流行性下痢病ウイルス(PEDV)のスパイク(S)抗原又は豚繁殖呼吸障害症候群ウイルス(PRRSV)のグリコプロテイン5(GP5)抗原をディスプレイすることで次世代型のワクチンを作り上げることである。そこで(1)ディスプレイ用抗原のカイコでの高効率生産、(2)九州大学のカイコ系統ライブラリーを利用したカイコの組換えタンパク質生産性の差異の原因探索、(3)タンパク質間のグルタミン残基とリジン残基を架橋する酵素である微生物由来トランスグルタミナーゼ (MTG)を用いた抗原提示VLPワクチン作製を課題として研究を進める。

    CiNii Research